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Introduction 
Infertility can be defined as the inability of a sexually 
active, non-contracepting couple to achieve spontaneous 
pregnancy after one year.1 It is a global problem that 
entails serious sexual and social consequences that strain 
the health sector and society as a whole.2 According to 
Agarwal et al., male factors account for 20-70% of 
infertility problems faced by the commonly quoted 15% 
of couples worldwide.3 This may be  due to congenital or 
acquired urogenital problems, abnormalities, genetic 
predisposition, immune system factor disorders of the 
immune system, infections, malignancies and/or 
endocrine malfunction, but 30% of the time, male 
infertility presents idiopathically.4 
Kisspeptin (KP) is one of the two RF-amide peptide 
hormone produced from the KISS1 gene via the plasma 
proteolytic cleavage of the gene product. Role of KP as a 
vital activator of reproductive endocrinological activity 
can be evidenced by the location of KISS1receptors in 
hypothalamus, basal ganglia and periventricular area 
(central nervous system [CNS]) as well as in structures like 
testis, spermatozoa, ovary and endometrium. KISS1 acts 
on KISS1 receptors on gonadotrophic-releasing hormone 
(GnRH) neurons and causes release, which increases the 
firing rate of GnRH neurons and further 
increasesLutenizing Hormone (LH) secretion by acting on 
gonadotrophs.5 Studies carried out to determine the role 
of KP in the regulation of the reproductive axis have 
documented an increase in oocyte maturity and clinical 
pregnancy rates of females after intracytoplasmic sperm 
injection (ICSI), especially in cases of unexplained 
infertility.6,7 Universally, researchers have mainly focussed 
on females, but recent shift in healthcare dynamics have 
instigated a fresh look into male infertility and the 
corresponding factors that influence its extent, severity 
and prevalence. Serum levels of KP  have been 
investigated in only limited number of studies which 
don't give the insights of the causative factors of male 
infertility.8,9 The current study was planned to determine 
the impact of KP on male reproductive axis in a selected 
urban population, and to bridge the gap by exploring the 
correlative and causative links between KP and the 
cascade of released hormones (Figure). 
Subjects and Methods 
The cross-sectional study was conducted at the Sindh 
Institute of Reproductive Medicine (SIRM) in collaboration 
with Aga Khan University (AKU), Karachi, from July, 2017, 
to February, 2018. After approval from the AKU 
ethicsreview board, the sample size was calculated to 
generate a power of 80% with 5% confidence interval 
(CI)10 while keeping the prevalence of male factor 
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infertility at 40%.3 Based on the calculation, infertile and 
fertile males aged 25-55 years regardless of their ethnic 
background were enrolled for the study after getting 
written informed consent from each of them. They were 
classified as infertile group which comprised males with a 
sperm concentration <15 × 106, decreased total sperm 
motility <40% and normal morphology <4%,11 and a 
fertile group which had males who had children and 
sperm concentration >15 × 106, total sperm motility 
>40% and normal morphology >4%.11 Male subjects with 
pre-existing diabetes and hypertension, and with serious 
general health status were excluded. Ten millilitreof 
venous blood from ante-cubital vein was collected from 
infertile males. Serum obtained by centrifugation of 
blood was stored at -70°C until further analysis. Serum 
follicle stimulating hormone (FSH) was determined by 
using commercially available kit for Human FSH Enzyme 
Immunoassay (Kit Cat. No KAPD1288 by DIA source 
Immuno Assays S.A. Belgium). Serum LH estimation was 
made using commercially available kit for Human LH 
Enzyme Immunoassay (Kit Cat. No KAPD1289 by DIA 
source Immuno Assays S.A. Belgium). For Elecsys FSH 
immunoassay, the inter-assay coefficient of variation (CV) 
<6% and intra-assay CV<3% were used. For Elecsys LH 
immunoassay the inter-assay 
CV was <6%, and intra-assay 
CV was <5%. Serum sex 
hormone-binding globulin 
(SHBG) estimation was done 
using commercially available 
kit for SHBG Enzyme 
Immunoassay (Kit Cat. No 
10222 by Glory Science Co, 
Ltd USA) following the 
manufacturer's protocol. 
Serum KP was measured 
using KISS1 enzyme-linked 
immunosorbent assay (ELISA) 
Kit (Cat.No: YHB1811Hu, 
Glory BioScience, USA) 
following the manufacturer's 
protocol. The analytical 
sensitivity was 10.16 ng/L and 
intra- and inter-assay CVs was 
less than 10% and 12%, 
respectively. 
Data was analysed using SPSS 
22. Descriptive statistics were 
computed for categorical 
variables by computing their 
frequencies and percentages, 
assessed by chi-square where 
expected frequency in each cell was >5 and Fisher's exact 
test where any one cell had frequency <5. The distribution 
of quantitative variables was computed by their means 
and standard deviations/ median and interquartile range 
(IQR) depending onthe normality of the data, and 
assessed by independent t test / Mann Whitney test. 
Correlation was assessed between quantitative variables 
by Pearson correlation for normally distributed data, and 
spearman correlation for non-normally distributed data. 
Unadjusted and adjusted prevalence ratio (PRs) with their 
95% CIs were reported using simple and multiple Cox 
regression. All plausible interactions and confounding 
factors were assessed. 
Results 
Of the 313 male subjects, 178(57%) were infertile and 
135(43%) were fertile. Median KP levels were higher 
among fertile males compared to infertile males (p 
<0.001). The mean age of the fertile participants was 
higher, but infertile males had a higher BMI and Body fat 
percentage (BF%) value compared to the fertile group 
(p<0.001). Mean FSH, LH and testosterone values were 
higher among fertile males (p<0.001). Median SHBG was 
higher among fertile males (p<0.001). A strong positive 
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Increased adiposity plays a pivotal role in disturbing the hypothalamic-pituitary-gonadal axis leading to decreased testosterone 
ultimately causing male infertility.  
GnRH: Gonadotropin releasing hormone; KP: Kisspeptin; LR: Leptin receptor; 
LH: Leutinizing hormone; FSH: Follicular stimulating hormone. 
 
Figure: Possible pathophysiology involved in causing male infertility.
correlation was observed between LH and testosterone 
(r=0.954; p=0.002) and between SHBG and LH (rho=0.933; 
p<0.001) (Table-1).  
Univariate analysis showed that with every one unit 
increase in KP, the prevalence of being infertile was 
decreased by 6.6%. Similarly, with every 1 unit increase in 
age (year), FSH (mIU/ml), LH (mIU/ml), testosterone 
(ng/ml) and SHBG, the prevalence of being infertile was 
decreased by 4.7%, 20%, 15.7%, 22.4% and 6.9% 
respectively. Moreover, with every 1 kg/m2 increase in 
BMI, the prevalence of being infertile increased by 6.9%. 
Likewise, the males who were obese (> 25kg/m2) were 
1.604 times more likely to be infertile compared to those 
who were of normal weight (CI:1.065-2.417).  
In the final Cox regression model which included KP, FSH 
and testosterone, it was observed that after adjusting for 
FSH and testosterone, with every one unit increase in KP, 
the prevalence of being infertile decreased by 2.7%. There 
was significant interaction between FSH and testosterone 
(p<0.1). Hence, with every 1 unit rise in serum 
testosterone level, the FSH led to 4.6% decrease in 
infertility (Table-2). 
Discussion 
The study observed low serum KP levels with reduced LH, 
FSH, testosterone, SHBG levels in male infertile subjects. 
The findings are similar to an earlier study.12 Further 
analysis showed that higher serum KP levels were 
associated with a significant increase in reproductive 
hormones, which suggested its crucial role in the central 
regulation of male reproductive axis and fertility. KP also 
exerts peripheral effects alongwith its central regulation 
resulting from its steroid-independent role in 
intermediating stress-induced suppression of 
reproductive functions.13 
The impact of KP on hypothalamo-pituitary gonadal 
(HPG) axis can further be complemented by the incidence 
of hypogonadotropic hypogonadism presenting with 
absent or delayed reproductive function and pubertal 
maturation, caused by mutations in the gene encoding 
for a G protein-coupled receptor (GPR54)of KISS1R. This 
key was further substantiated by a demonstration in 
which mice lacking functional GPR54 or KISS1 genes were 
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Table-1: Clinical and biochemical characteristic of fertile and infertile males. 
 
Factors                                                 Infertile (n=178)       Infertile (n=135)    P value 
                                                                       Mean ± SD                     Mean ± SD 
 
Age (in years)                                            33.74 ± 5.67                   37.65 ± 6.12           <0.001 
BMI (in kg/m2)                                          26.67 ± 3.59                   24.76 ± 3.08           <0.001 
Body Fat (%)                                               34.37±4.66                     32.97±4.06              0.006 
FSH (in mIU/ml)                                         3.41 ± 1.97                      6.31 ± 2.50            <0.001 
LH (in mIU/ml)                                           5.45 ± 2.90                      9.96 ± 2.58            <0.001 
Testosterone (in ng/ml)                          3.35 ± 1.92                      8.16 ± 1.38            <0.001 
 
                                                                    Median (IQR)                Median (IQR)                  
SHBG (nmol/L)                                   15.44 (12.06-18.95)      32.06 (25.98-30.71)    <0.001 
Kisspeptin (ng/ml)                                6.25 (5.65-6.95)           16.25(15.6-43.75)      <0.001 
 
                                                                         Absolute                         Absolute                      
                                                                         count (%)                       count (%) 
Normal weight (18 - 22.9 kg/m2)        28 (15.7%)                       41 (30.4%)             <0.001 
Overweight (23 - 24.9 kg/m2)               25 (14.0%)                       27 (20.0%)                     
Obese (> 25 kg/m2)                                 125(70.2%)                      67 (49.6%)                     
 
*Significant at p value <0.05 
SD: Standard deviation; BMI: Body mass index; FSH: Follicle stimulating hormone;LH: Luteinizing 
hormone; SHBG: Sex hormone-binding globulin.
Table-2: Interface of Kisspeptin (KP), clinical and hormonal profile and the risk of infertility by univariate and multivariate analysis. 
 
Factors                                              Unadjusted Prevalence Ratio (95% CI)                              P value                                     Adjusted Prevalence Ratio (95% CI)                                P value 
 
Age (year)                                                                0.953(0.929-0.978)                                                     <0.001*                                                                         --                                                                            -- 
Normal weight                                                                 Reference                                                                     --                                                                                -- 
Overweight                                                              1.185(0.691-2.032)                                                        0.047                                                                            --                                                                            -- 
Obese                                                                        1.604(1.065-2.417)                                                        0.002                                                                            --                                                                            -- 
Body Fat (%)                                                           1.031(0.998-1.066)                                                         0.07                                                                              --                                                                            -- 
LH (in mIU/ml) 
0.843(0.805-0.882)                                                          <0.001                                                                       --                                                                                -- 
SHBG nmol/L                                                           0.931(0.912-0.950)                                                      <0.001                                                                           --                                                                            -- 
Kisspeptin(ng/ml)                                                 0.934 (0.912-0.957)                                                     <0.001                                                         0.973 (0.954-0.993)                                                     0.008* 
FSH (mIU/ml)                                                          0.796(0.740-0.855)                                                      <0.001                                                         1.091(0.957-1.243)                                                       0.193 
Testosterone (ng/ml)                                          0.776(0.735-0. 820)                                                     <0.001                                                         1.011(0.886-1.153)                                                       0.873 
FSH* Testosterone                                                                  --                                                                             --                                                               0.954(0.927-0.983)                                                       0.002 
 
*Significant at p value < 0.05 
# Significant at p value < 0.1 
FSH: Follicle stimulating hormone;LH: Luteinizing hormone; SHBG: Sex hormone-binding globulin.
phenocopies of the humans affected.14 Jayasena et al. 
reported that exogenously-administered Kisspeptin-10 
bolus even at low doses stimulated gonadotropin 
release15 in males primarily but also in women during the 
pre-ovulatory phase of the menstrual cycle. 
The observation by the current study of increase in FSH 
and LH secretion is supported by studies that 
documented KP as a powerful stimulator of LH and FSH 
release, both after intra-cerebral and systemic 
administration of the peptide.16 The increased LH 
secretion in fertile males with increased KP is supported 
by Pinilla et al. who reported that KP plays a crucial role in 
increased LH secretion, and to lesser extent FSH secretion 
as well.5 George et al. further complemented this report 
by discovering that exogenous KP-10 administration 
resulted in an increase in LH pulse frequency and 
secretion, with increased testosterone levels in the 
hypogonadal men suffering from type 2 diabetes.17 We 
observed increased concentration of both LH and FSH 
which is contrary to a study which documented greater 
sensitivity of LH release to the stimulatory effect of KP in 
comparison to FSH.16 
Down-streaming the HPG axis, KP potentially increased 
the serum testosterone levels in normal males which is 
comparable to Dhillo et al.18 In addition, it has also been 
demonstrated that systemic KP administration in males 
who are infertile and/or have azoospermia can cause 
increased testosterone secretion in addition to LH and 
FSH. However, chronic increase may lead to testicular 
atrophy, causing a drop in testosterone levels and an 
increase, decrease or no change in LH and FSH levels.18 
We also observed a strong positive correlation between 
LH and testosterone. This causal relationship and the 
reversibility of the levels has been authenticated with a 
decrease in weight loss.19 
Obesity alters fertility both centrally and peripherally. The 
anticipated patho-physiological mechanisms thus explain 
the multi-factorial relationships involved. Apart from 
influencing the HPG axis and the aromatisation, truncal 
obesity also causes hypoxaemia during sleep apnoea, 
which might disrupt the morning testosterone 
secretion.20 Additionally, there is loss of sperm 
deoxyribonucleic acid (DNA) integrity caused by the 
activation of seminal macrophage due to enhanced redox 
activity in obese men.21 Nevertheless the psychological 
influence can also lead to erectile dysfunctions.22 
Literature insinuates links between degree of obesity and 
male fertility by affecting the total testosterone,oestrogen 
and reduced Sertoli cell functions.23 This might be on 
account of increased white adipose tissue present in 
obese males. White adipocytes are accountable for the 
aromatase activity within the adipocytes that converts 
available testosterone to estradiol, resulting in decreased 
testosterone level in such individuals. Simultaneously, 
oestrogens stored in the fat tissues act as a suppressor on 
the HPG axis. Decreasing the GnRH release ultimately 
lowers the secretion of LH and FSH, leading to diminished 
gonadal testosterone release Therefore, it is possible that 
the high BF% in our subjects could have an indirect effect 
on testosterone levels modulating the HPG axis. Leptin is 
an adipokine that regulates body composition and satiety 
(Figure). In addition, it also stimulates GnRH neurons in 
the hypothalamus to induce LH release and subsequent 
testicular stimulation of testosterone release under 
normal conditions.24 A previous study showed a relation 
of Leptin-KP axis in female infertility; expressed by 
maximum number of clinical pregnancies in the group 
that showed strongest relationship between serum 
Leptin and KP levels.25  GnRH neurons have little or no 
leptin receptor expression but possess the KP receptor 
and KP neurons that express the leptin receptor, thus 
modulating the GnRH secretion. However, hypothalamic 
leptin resistance is common in obesity, leading to a loss of 
feedback stimulation of testosterone production.25 
After adjusting for covariates FSH and testosterone, 
chances of becoming infertile increased with every one 
unit increase in KP. The causative effect between KP levels 
and the changes in the reproductive status, however, 
needs to be explored further.The current study is 
complimentary in nature because majority of studies 
have focussed on the hypothalamic and pituitary impact 
of KP administration as opposed to serum hormonal and 
protein biomarker levels. 
Conclusion 
KP plays an important role in male fertility by increasing 
the production of hormones of the male reproductive 
axis; namely FSH, LH and testosterone. Absence of 
negative feedback inhibition of KP by increased 
testosterone supports its production from peripheral 
reproductive organs besides central nervous system. 
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